Emerging Role of Vedolizumab in Managing Refractory Immune Checkpoint Inhibitor–Induced Enteritis

We report a 62-year-old white woman with metastatic choroidal melanoma who developed immune checkpoint inhibitor (ICI)-induced enteritis and grade 3 diarrhea refractory to steroids and infliximab. Her diarrhea quickly resolved after infusion of vedolizumab, and the patient was able to taper down ste...

Descripción completa

Detalles Bibliográficos
Autores principales: Diana, Pietro, Mankongpaisarnrung, Charoen, Atkins, Michael B., Zeck, Jay C., Charabaty, Aline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Gastroenterology 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830540/
https://www.ncbi.nlm.nih.gov/pubmed/29516018
http://dx.doi.org/10.14309/crj.2018.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830540/
https://www.ncbi.nlm.nih.gov/pubmed/29516018
http://dx.doi.org/10.14309/crj.2018.17

Ejemplares similares